These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11752220)

  • 1. The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step.
    Papandréou MJ; Barbouche R; Guieu R; Kieny MP; Fenouillet E
    Mol Pharmacol; 2002 Jan; 61(1):186-93. PubMed ID: 11752220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional.
    Fenouillet E; Papandréou MJ; Jones IM
    Virology; 1997 Apr; 231(1):89-95. PubMed ID: 9143306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain.
    Papandreou MJ; Fenouillet E
    Virology; 1998 Feb; 241(1):163-7. PubMed ID: 9454727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
    Fenouillet E; Gluckman JC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor.
    Yuan W; Craig S; Si Z; Farzan M; Sodroski J
    J Virol; 2004 May; 78(10):5448-57. PubMed ID: 15113923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2001 Nov; 75(22):11096-105. PubMed ID: 11602749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.
    Salzwedel K; Smith ED; Dey B; Berger EA
    J Virol; 2000 Jan; 74(1):326-33. PubMed ID: 10590121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.
    Fischer PB; Karlsson GB; Butters TD; Dwek RA; Platt FM
    J Virol; 1996 Oct; 70(10):7143-52. PubMed ID: 8794361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
    Reeves JD; Gallo SA; Ahmad N; Miamidian JL; Harvey PE; Sharron M; Pohlmann S; Sfakianos JN; Derdeyn CA; Blumenthal R; Hunter E; Doms RW
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16249-54. PubMed ID: 12444251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.
    Missé D; Cerutti M; Schmidt I; Jansen A; Devauchelle G; Jansen F; Veas F
    J Virol; 1998 Sep; 72(9):7280-8. PubMed ID: 9696823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
    Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
    J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.
    Bandres JC; Wang QF; O'Leary J; Baleaux F; Amara A; Hoxie JA; Zolla-Pazner S; Gorny MK
    J Virol; 1998 Mar; 72(3):2500-4. PubMed ID: 9499113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion.
    Gallo SA; Reeves JD; Garg H; Foley B; Doms RW; Blumenthal R
    Retrovirology; 2006 Dec; 3():90. PubMed ID: 17144914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin.
    Pal R; Kalyanaraman VS; Hoke GM; Sarngadharan MG
    Intervirology; 1989; 30(1):27-35. PubMed ID: 2542177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
    Mori T; Boyd MR
    Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
    König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
    J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.